Protalix BioTherapeutics to Participate in the 18th Annual WORLDSymposium™ 2022

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and...

Related Keywords

University Of Iowa Health Care ,Iowa ,United States ,Iowa City ,United Kingdom ,Israel ,Brazil ,California ,San Diego ,London ,City Of ,Carmiel ,Ha Afon ,American ,Derralynn Hughes ,Chiesi Farmaceutici ,Myrld Holida ,Chuck Padala ,University College London ,Protalix Biotherapeutics Inc ,Pfizer Inc ,Drug Administration ,Manchester Grand Hyatt ,Pegunigalsidase Alfa Administered Every ,Fabry Disease ,Iowa Health Care ,Multicenter Extension Study ,Adult Patients ,Protalix Biotherapeutics ,Nc ,